Subscribe

Lifecore Biomedical, Inc. (LFCR)

USD4.81 +0.20 (+4.28%)
US NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
Address 3515 Lyman Boulevard 55318
Chaska, MN, US
CEO Paul Josephs
IPO 1996-02-15
CIK 1005286 ISIN US5147661046

Explore sections of this company profile

Also trades on NASDAQ Global Select · LFCR (USD) NASDAQ Global Select · LNDC (USD)
Description

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD4.81 +0.20 (+4.28%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
253.8K
Beta
1.07
Float Shares
34.17M
Free Float %
91.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+1.33% -8.62% -4.00% -34.86% -44.53% -44.25% -34.67% +6.05% -60.89% -59.47% -64.24%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (7 ratings, all time) Buy
Price Targets & DCF
Current price
4.81
Low 6.00 +24.8%
Consensus 6.00 +24.8%
Median 6.00 +24.8%
High 6.00 +24.8%
Ratings Trend (MoM) 60% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 2 0
Hold 2 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month 1
6.00
+24.8%
Last Quarter 1
6.00
+24.8%
Last Year 1
6.00
+24.8%
All Time 3
6.33
+31.7%
Quality scores
Altman Z-Score
-0.15
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%
    +0.5% Q1'26: -34.0% (vs Q1'25)
  • EPS growth Drug Manufacturers - Specialty & Generic: +16.5%
    -484.9% Q1'26: +8.5% (vs Q1'25)
  • FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%
    -33.7% Q1'26: +15.4% (vs Q1'25)
  • EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%
    -13.1% Q1'26: -20.1% (vs Q1'25)
  • ROIC Drug Manufacturers - Specialty & Generic: +6.5%
    -13.6% Q1'26: -12.4% (vs Q1'25)
  • Share dilution Drug Manufacturers - Specialty & Generic: +0.0%
    -5.0% Q1'26: +1.2% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×
    -14.85× Q1'26: -15.89× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.08) × ERP
WACC = 57% × Ke + 43% × Kd (16.7%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 4.81
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric May 2015
actual
May 2016
actual
May 2017
actual
May 2018
actual
May 2019
actual
May 2020
actual
May 2021
actual
May 2022
actual
May 2023
actual
May 2024
actual
May 2025
actual
May 2026
3 Rev. Ana.
2 EPS Ana.
May 2027
4 Rev. Ana.
2 EPS Ana.
May 2028
4 Rev. Ana.
1 EPS Ana.
May 2029
2 Rev. Ana.
1 EPS Ana.
May 2030
2 Rev. Ana.
1 EPS Ana.
Revenue
539.26M
est: 539.95M (-0.1%)
541.10M
est: 535.88M (+1.0%)
532.26M
est: 540.28M (-1.5%)
524.23M
est: 547.75M (-4.3%)
557.56M
est: 555.46M (+0.4%)
160.07M
est: 590.21M (-72.9%)
100.87M
est: 528.90M (-80.9%)
111.27M
est: 183.76M (-39.4%)
103.27M
est: 121.88M (-15.3%)
128.26M
est: 125.39M (+2.3%)
128.87M
est: 127.81M (+0.8%)
75.12M
73.08M – 77.62M
-41.2% YoY
122.23M
119.51M – 124.40M
+62.7% YoY
130.29M
128.52M – 132.09M
+6.6% YoY
150.29M
148.25M – 152.37M
+15.4% YoY
182.46M
179.98M – 184.98M
+21.4% YoY
EBITDA
30.39M
est: -685.1K (+4,536.0%)
-7.80M
est: -679.9K (-1,046.9%)
26.68M
est: -685.5K (+3,991.8%)
24.99M
est: -695.0K (+3,695.4%)
23.47M
est: -704.8K (+3,430.2%)
-7.16M
est: -748.8K (-856.3%)
-987.0K
est: -671.0K (-47.1%)
12.84M
est: -233.1K (+5,608.9%)
-33.17M
est: -154.6K (-21,350.9%)
35.60M
est: -159.1K (+22,479.5%)
-8.81M
est: -162.2K (-5,334.0%)
-95.3K
-98.5K – -92.7K
+41.2% YoY
-155.1K
-157.8K – -151.6K
-62.7% YoY
-165.3K
-167.6K – -163.1K
-6.6% YoY
-190.7K
-193.3K – -188.1K
-15.4% YoY
-231.5K
-234.7K – -228.4K
-21.4% YoY
EBIT
18.46M
est: -66.72M (+127.7%)
-16.87M
est: -66.22M (+74.5%)
16.00M
est: -66.77M (+124.0%)
13.59M
est: -67.69M (+120.1%)
8.87M
est: -68.64M (+112.9%)
-26.00M
est: -72.93M (+64.4%)
-20.85M
est: -65.36M (+68.1%)
-5.22M
est: -22.71M (+77.0%)
-46.35M
est: -15.06M (-207.7%)
27.60M
est: -15.50M (+278.1%)
-16.84M
est: -15.79M (-6.6%)
-9.28M
-9.59M – -9.03M
+41.2% YoY
-15.10M
-15.37M – -14.77M
-62.7% YoY
-16.10M
-16.32M – -15.88M
-6.6% YoY
-18.57M
-18.83M – -18.32M
-15.4% YoY
-22.55M
-22.86M – -22.24M
-21.4% YoY
Net Income
13.54M
est: 18.87M (-28.2%)
-11.64M
est: 11.89M (-197.9%)
10.59M
est: 15.93M (-33.5%)
24.83M
est: 13.75M (+80.5%)
2.12M
est: 174.1K (+1,118.9%)
-38.19M
est: -46.83M (+18.5%)
-32.29M
est: -36.00M (+10.3%)
-116.72M
est: -68.83M (-69.6%)
-99.56M
est: -82.96M (-20.0%)
12.01M
est: 14.28M (-15.9%)
-38.72M
est: -44.36M (+12.7%)
-16.71M
-17.50M – -15.93M
+62.3% YoY
-35.03M
-36.22M – -33.85M
-109.6% YoY
-34.30M
-34.91M – -33.69M
+2.1% YoY
-41.09M
-41.83M – -40.36M
-19.8% YoY
-22.63M
-23.04M – -22.23M
+44.9% YoY
SGA
39.96M
est: 175.04M (-77.2%)
49.52M
est: 173.72M (-71.5%)
58.21M
est: 175.15M (-66.8%)
51.95M
est: 177.57M (-70.7%)
64.06M
est: 180.07M (-64.4%)
40.67M
est: 191.34M (-78.7%)
27.72M
est: 171.46M (-83.8%)
34.66M
est: 59.57M (-41.8%)
38.97M
est: 39.51M (-1.4%)
40.46M
est: 40.65M (-0.5%)
44.05M
est: 41.43M (+6.3%)
24.35M
23.69M – 25.16M
-41.2% YoY
39.63M
38.74M – 40.33M
+62.7% YoY
42.24M
41.66M – 42.82M
+6.6% YoY
48.72M
48.06M – 49.40M
+15.4% YoY
59.15M
58.35M – 59.97M
+21.4% YoY
EPS
0.50
est: 0.54 (-7.7%)
-0.43
est: 0.34 (-225.9%)
0.39
est: 0.46 (-14.8%)
0.90
est: 0.40 (+127.8%)
0.07
est: 0.01 (+1,396.0%)
-1.31
est: -1.35 (+2.6%)
-1.12
est: -1.03 (-8.3%)
-3.97
est: -1.98 (-100.8%)
-3.32
est: -2.38 (-39.5%)
0.39
est: 0.41 (-4.9%)
-1.27
est: -1.33 (+4.5%)
-0.48
-0.50 – -0.46
+63.9% YoY
-1.02
-1.04 – -0.97
-112.0% YoY
-0.99
-1.00 – -0.97
+3.2% YoY
-1.18
-1.20 – -1.16
-19.8% YoY
-0.65
-0.66 – -0.64
+44.9% YoY
Recent Grade Changes (3M)
Date Firm Previous New Grade Action
2026-04-29 Barrington Research Outperform Outperform Maintain
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-12 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-11 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-08 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-07 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-06 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-05 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-04 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-01 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-30 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-29 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-28 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-27 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-24 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-23 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-22 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-21 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-20 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-17 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-16 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
14.59M
OE per share TTM
0.39
Owner's Yield
7.85%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
85.0%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
21
Total invested
905.6K
Insider transactions (90d)
0
Beneficial owners (>5%)
18
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Christopher S. Kiper 6.46M 16.60% 6.46M IN 2024-10-07
2 Legion Partners Holdings, LLC 6.46M 16.60% 6.46M OO 2024-10-07
3 Raymond T. White 6.46M 16.60% 6.46M IN 2024-10-07
4 Legion Partners Asset Management, LLC 6.46M 16.60% 6.46M IA, OO 2024-10-07
5 Legion Partners, LLC 6.43M 16.60% 6.43M OO 2024-10-07
6 Legion Partners, L.P. I 5.94M 15.40% 5.94M PN 2024-10-07
7 22NW Fund GP, LLC 3.10M 9.99% 3.10M 10.00 OO 2023-01-10
8 22NW Fund, LP 3.10M 9.99% 3.10M 10.00 PN 2023-01-10
9 22NW GP, Inc. 3.10M 9.99% 3.10M 10.00 CO 2023-01-10
10 22NW, LP 3.10M 9.99% 3.10M 10.00 PN 2023-01-10
11 Aron R. English 3.10M 9.99% 3.10M 10.00 IN 2023-01-10
12 Cove Street Capital, LLC 27-5376591 2.37M 7.89% 418.6K 1.13M 418.6K 1.96M IA DELAWARE 2023-01-12
13 Jeffrey Bronchick 2.37M 7.89% 418.00 1.13M 418.6K 1.96M IN DELAWARE 2023-01-12
14 Scott Miller 1.90M 6.30% 1.90M 1.90M IN USA 2023-06-30
15 Legion Partners, L.P. II 495.7K 1.30% 495.7K PN 2024-10-07
16 Partners Fund, LP 418.6K 1.39% 418.6K 418.6K PN DELAWARE 2023-01-12
17 Bryson O. Hirai-Hadley 583.00 1.00% 583.00 10.00 IN 2023-01-10
18 Ryan W. Broderick 575.00 1.00% 575.00 10.00 IN 2023-01-10

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
21
-86 vs prev Q
New positions
2
Closed positions
84
Increased
7
Reduced
7
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 WYNNEFIELD CAPITAL INC 4.70M +— (+0.0%) 38.47M +3.9M (+11.1%) 12.57% -0.128 pp 21.63% +0.828 pp USD10.72 -23.7% 51 qtrs
2 LEGION PARTNERS ASSET MANAGEMENT, LLC 4.46M +— (+0.0%) 36.50M +3.7M (+11.1%) 11.93% -0.121 pp 21.25% +3.479 pp USD8.81 -7.2% 26 qtrs
3 GREENHAVEN ROAD INVESTMENT MANAGEMENT, L.P. 3.68M -12.3K (-0.3%) 30.12M +2.9M (+10.8%) 9.85% -0.133 pp 5.07% +1.058 pp USD6.89 +18.7% 12 qtrs
4 22NW, LP 1.3K +— (+0.0%) 23.03M +2.9M (+14.3%) 0.00% +0.000 pp 9.69% +0.200 pp USD10.23 -20.0% 19 qtrs
5 325 CAPITAL LLC 2.16M +— (+0.0%) 17.69M +1.8M (+11.1%) 5.78% -0.059 pp 6.20% +1.361 pp USD6.60 +23.9% 9 qtrs
6 BLACKROCK, INC. 1.91M +66.4K (+3.6%) 15.60M +2.1M (+15.2%) 5.10% +0.128 pp 0.00% +0.000 pp USD5.52 +48.2% 6 qtrs
7 VANGUARD GROUP INC 1.67M +50.9K (+3.1%) 13.69M +1.7M (+14.6%) 4.47% +0.092 pp 0.00% +0.000 pp USD11.86 -31.0% 84 qtrs
8 GEODE CAPITAL MANAGEMENT, LLC 779.6K +6.0K (+0.8%) 6.38M +683.7K (+12.0%) 2.08% -0.005 pp 0.00% +0.000 pp USD7.45 +9.8% 78 qtrs
9 MORGAN STANLEY 751.5K +41.8K (+5.9%) 6.15M +923.9K (+17.7%) 2.01% +0.093 pp 0.00% +0.000 pp USD7.69 +6.4% 51 qtrs
10 GRIZZLYROCK CAPITAL, LLC 743.2K +4.4K (+0.6%) 6.08M +641.5K (+11.8%) 1.99% -0.008 pp 4.55% +0.328 pp USD8.12 +0.7% 3 qtrs
11 STATE STREET CORP 585.4K +46.1K (+8.5%) 4.79M +819.3K (+20.6%) 1.57% +0.109 pp 0.00% +0.000 pp USD7.81 +4.7% 51 qtrs
12 DCF ADVISERS, LLC 442.0K -10.0K (-2.2%) 3.62M +288.8K (+8.7%) 1.18% -0.039 pp 0.97% -0.099 pp USD7.38 +10.8% 11 qtrs
13 MILLENNIUM MANAGEMENT LLC 251.7K +116.5K (+86.2%) 2.06M +1.1M (+106.9%) 0.67% +0.308 pp 0.00% +0.000 pp USD7.65 +6.9% 4 qtrs
14 QUINN OPPORTUNITY PARTNERS LLC 242.7K +58.2K (+31.5%) 1.99M +627.3K (+46.2%) 0.65% +0.151 pp 0.08% -0.013 pp USD6.79 +20.5% 8 qtrs
15 NORTHERN TRUST CORP 225.0K -13.7K (-5.7%) 1.84M +83.8K (+4.8%) 0.60% -0.043 pp 0.00% +0.000 pp USD7.39 +10.7% 51 qtrs
16 TOCQUEVILLE ASSET MANAGEMENT L.P. 151.7K +— (+0.0%) 1.24M +124.4K (+11.1%) 0.41% -0.004 pp 0.02% +0.002 pp USD10.51 -22.2% 27 qtrs
17 JANE STREET GROUP, LLC 119.4K +53.2K (+80.2%) 977.1K +489.3K (+100.3%) 0.32% +0.129 pp 0.00% +0.000 pp USD7.73 +5.8% 2 qtrs
18 DIAMETRIC CAPITAL, LP 117.6K +91.8K (+356.1%) 961.9K +772.1K (+406.9%) 0.31% +0.245 pp 0.26% +0.187 pp USD8.17 +0.1% 9 qtrs
19 LPL FINANCIAL LLC 112.8K -35.4K (-23.9%) 922.6K -168.1K (-15.4%) 0.30% -0.099 pp 0.00% 0.000 pp USD7.06 +15.9% 4 qtrs
20 MARSHALL WACE, LLP 110.6K -3.5K (-3.0%) 904.9K +65.3K (+7.8%) 0.30% -0.012 pp 0.00% +0.000 pp USD7.10 +15.2% 11 qtrs
21 SQUAREPOINT OPS LLC 110.5K -40.4K (-26.8%) 903.9K -206.8K (-18.6%) 0.30% -0.112 pp 0.00% 0.000 pp USD7.17 +14.1% 6 qtrs
22 GOLDMAN SACHS GROUP INC 93.7K +38.3K (+69.2%) 766.1K +358.8K (+88.1%) 0.25% +0.101 pp 0.00% +0.000 pp USD7.27 +12.5% 58 qtrs
23 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 87.7K +26.0 (+0.0%) 717.5K +72.1K (+11.2%) 0.23% -0.002 pp 0.00% +0.000 pp USD6.38 +28.2% 76 qtrs
24 GAMCO INVESTORS, INC. ET AL 83.8K -700.0 (-0.8%) 685.5K +63.6K (+10.2%) 0.22% -0.004 pp 0.01% +0.001 pp USD9.70 -15.7% 19 qtrs
25 GSA CAPITAL PARTNERS LLP 82.8K +82.8K (+100.0%) 677.0K +677.0K (+100.0%) 0.22% +0.221 pp 0.06% +0.058 pp USD8.18 +0.0% 1 qtrs NEW
26 75.0K +75.0K (+100.0%) 613.5K +613.5K (+100.0%) 0.20% +0.201 pp 0.39% +0.395 pp USD8.18 +0.0% 1 qtrs NEW
27 PALE FIRE CAPITAL SE 71.0K +6.4K (+9.9%) 581.1K +105.5K (+22.2%) 0.19% +0.015 pp 0.04% -0.013 pp USD7.76 +5.4% 3 qtrs
28 CITADEL ADVISORS LLC 69.2K +69.2K (+100.0%) 566.1K +566.1K (+100.0%) 0.19% +0.185 pp 0.00% +0.000 pp USD8.18 +0.0% 1 qtrs NEW
29 BRIDGEWAY CAPITAL MANAGEMENT, LLC 61.8K +— (+0.0%) 505.5K +50.7K (+11.1%) 0.17% -0.002 pp 0.01% +0.001 pp USD5.83 +40.3% 8 qtrs
30 BANK OF NEW YORK MELLON CORP 58.9K -26.0K (-30.6%) 481.7K -142.9K (-22.9%) 0.16% -0.072 pp 0.00% +0.000 pp USD5.93 +37.9% 66 qtrs
31 UBS GROUP AG 54.8K -38.1K (-41.0%) 447.9K -235.3K (-34.4%) 0.15% -0.104 pp 0.00% +0.000 pp USD7.21 +13.5% 45 qtrs
32 BARCLAYS PLC 46.7K +16.8K (+55.9%) 382.0K +234.3K (+158.7%) 0.12% +0.044 pp 0.00% +0.000 pp USD7.14 +14.6% 38 qtrs
33 STATE OF WISCONSIN INVESTMENT BOARD 37.8K +21.9K (+138.2%) 309.4K +192.5K (+164.7%) 0.10% +0.058 pp 0.00% +0.000 pp USD7.84 +4.3% 2 qtrs
34 D. E. SHAW & CO., INC. 37.4K +37.4K (+100.0%) 306.2K +306.2K (+100.0%) 0.10% +0.100 pp 0.00% +0.000 pp USD8.18 +0.0% 1 qtrs NEW
35 NUVEEN, LLC 35.9K +— (+0.0%) 293.3K +29.4K (+11.1%) 0.10% -0.001 pp 0.00% +0.000 pp USD7.25 +12.8% 4 qtrs
36 STEWARD PARTNERS INVESTMENT ADVISORY, LLC 34.2K +326.0 (+1.0%) 279.9K +30.5K (+12.2%) 0.09% 0.000 pp 0.00% +0.000 pp USD6.36 +28.6% 10 qtrs
37 RHUMBLINE ADVISERS 33.7K -3.7K (-9.9%) 275.6K +391.0 (+0.1%) 0.09% -0.011 pp 0.00% +0.000 pp USD6.99 +17.0% 55 qtrs
38 WELLS FARGO & COMPANY/MN 30.8K +12.6K (+69.7%) 251.6K +118.2K (+88.6%) 0.08% +0.033 pp 0.00% +0.000 pp USD6.85 +19.4% 57 qtrs
39 TWO SIGMA INVESTMENTS, LP 27.8K +27.8K (+100.0%) 227.4K +227.4K (+100.0%) 0.07% +0.074 pp 0.00% +0.000 pp USD8.18 +0.0% 1 qtrs NEW
40 BANK OF AMERICA CORP /DE/ 26.3K +9.1K (+52.4%) 215.4K +88.2K (+69.4%) 0.07% +0.024 pp 0.00% +0.000 pp USD6.94 +17.9% 52 qtrs
41 WITTENBERG INVESTMENT MANAGEMENT, INC. 21.7K +4.5K (+26.1%) 177.7K +50.9K (+40.2%) 0.06% +0.012 pp 0.07% +0.018 pp USD6.41 +27.6% 7 qtrs
42 DEUTSCHE BANK AG\ 20.9K -5.8K (-21.5%) 171.3K -25.1K (-12.8%) 0.06% -0.016 pp 0.00% +0.000 pp USD7.34 +11.4% 50 qtrs
43 PHARVISION ADVISERS, LLC 19.0K -1.5K (-7.2%) 155.8K +4.8K (+3.2%) 0.05% -0.005 pp 0.08% -0.006 pp USD7.36 +11.1% 2 qtrs
44 PRELUDE CAPITAL MANAGEMENT, LLC 18.8K +18.8K (+100.0%) 154.0K +154.0K (+100.0%) 0.05% +0.050 pp 0.01% +0.011 pp USD8.18 +0.0% 6 qtrs
45 DIVERSIFIED TRUST CO 18.1K +— (+0.0%) 148.4K +14.9K (+11.1%) 0.05% -0.001 pp 0.00% +0.000 pp USD9.97 -18.0% 17 qtrs
46 PRICE T ROWE ASSOCIATES INC /MD/ 16.6K +2.8K (+20.4%) 137.0K +35.0K (+34.3%) 0.04% +0.007 pp 0.00% +0.000 pp USD7.40 +10.5% 4 qtrs
47 SUSQUEHANNA INTERNATIONAL GROUP, LLP 16.5K +16.5K (+100.0%) 135.0K +135.0K (+100.0%) 0.04% +0.044 pp 0.00% +0.000 pp USD8.18 +0.0% 1 qtrs NEW
48 AQR CAPITAL MANAGEMENT LLC 16.2K +3.6K (+28.4%) 132.3K +39.6K (+42.7%) 0.04% +0.009 pp 0.00% +0.000 pp USD8.08 +1.2% 3 qtrs
49 POINT72 ASSET MANAGEMENT, L.P. 15.7K +15.7K (+100.0%) 128.1K +128.1K (+100.0%) 0.04% +0.042 pp 0.00% +0.000 pp USD8.18 +0.0% 1 qtrs NEW
50 TWO SIGMA ADVISERS, LP 15.3K +15.3K (+100.0%) 124.9K +124.9K (+100.0%) 0.04% +0.041 pp 0.00% +0.000 pp USD8.18 +0.0% 1 qtrs NEW
51 JPMORGAN CHASE & CO 15.2K +2.9K (+23.7%) 124.5K +34.0K (+37.5%) 0.04% +0.008 pp 0.00% +0.000 pp USD6.23 +31.3% 33 qtrs
52 JUMP FINANCIAL, LLC 15.1K +15.1K (+100.0%) 123.2K +123.2K (+100.0%) 0.04% +0.040 pp 0.00% +0.002 pp USD8.18 +0.0% 1 qtrs NEW
53 INVESCO LTD. 14.8K +1.2K (+9.1%) 121.4K +21.2K (+21.2%) 0.04% +0.003 pp 0.00% +0.000 pp USD8.12 +0.7% 5 qtrs
54 GRAHAM CAPITAL MANAGEMENT, L.P. 13.6K +13.6K (+100.0%) 111.1K +111.1K (+100.0%) 0.04% +0.036 pp 0.00% +0.003 pp USD8.18 +0.0% 1 qtrs NEW
55 GABELLI FUNDS LLC 13.5K +— (+0.0%) 110.4K +11.1K (+11.1%) 0.04% 0.000 pp 0.00% +0.000 pp USD9.97 -18.0% 21 qtrs
56 MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 13.2K +654.0 (+5.2%) 107.9K +15.6K (+16.9%) 0.04% +0.001 pp 0.00% +0.000 pp USD5.59 +46.3% 6 qtrs
57 GWN SECURITIES INC. 12.4K -254.0 (-2.0%) 101.2K +8.1K (+8.8%) 0.03% -0.001 pp 0.02% -0.001 pp USD8.12 +0.7% 3 qtrs
58 INTECH INVESTMENT MANAGEMENT LLC 11.7K -1.7K (-12.5%) 95.9K -2.7K (-2.8%) 0.03% -0.005 pp 0.00% +0.000 pp USD7.70 +6.2% 5 qtrs
59 METLIFE INVESTMENT MANAGEMENT, LLC 10.7K -5.8K (-35.4%) 87.2K -34.2K (-28.2%) 0.03% -0.016 pp 0.00% 0.000 pp USD7.61 +7.5% 5 qtrs
60 COVESTOR LTD 8.3K +944.0 (+12.8%) 68.0K +14.0K (+25.9%) 0.02% +0.002 pp 0.04% +0.006 pp USD6.54 +25.1% 12 qtrs
61 PINNACLE WEALTH PLANNING SERVICES, INC. 7.4K +7.4K (+100.0%) 60.2K +60.2K (+100.0%) 0.02% +0.020 pp 0.01% +0.006 pp USD8.18 +0.0% 1 qtrs NEW
62 BNP PARIBAS ARBITRAGE, SNC 6.8K +1.0K (+17.9%) 55.8K +13.2K (+31.0%) 0.02% +0.003 pp 0.00% +0.000 pp USD6.97 +17.4% 46 qtrs
63 CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. 6.1K +6.1K (+100.0%) 49.9K +49.9K (+100.0%) 0.02% +0.016 pp 0.00% +0.004 pp USD8.18 +0.0% 1 qtrs NEW
64 POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY 5.7K +— (+0.0%) 46.7K +4.7K (+11.1%) 0.02% 0.000 pp 0.00% +0.000 pp USD7.43 +10.1% 5 qtrs
65 MASSMUTUAL TRUST CO FSB/ADV 3.4K +— (+0.0%) 28.1K +2.8K (+11.1%) 0.01% 0.000 pp 0.00% +0.000 pp USD7.43 +10.1% 5 qtrs
66 FMR LLC 3.2K +422.0 (+15.0%) 26.4K +5.8K (+27.8%) 0.01% +0.001 pp 0.00% +0.000 pp USD6.83 +19.8% 16 qtrs
67 RUSSELL INVESTMENTS GROUP, LTD. 3.0K -105.0 (-3.4%) 24.2K +1.7K (+7.3%) 0.01% 0.000 pp 0.00% +0.000 pp USD7.42 +10.2% 3 qtrs
68 LEGAL & GENERAL GROUP PLC 2.7K -130.0 (-4.6%) 21.9K +1.2K (+6.0%) 0.01% 0.000 pp 0.00% +0.000 pp USD5.67 +44.3% 7 qtrs
69 AMERITAS INVESTMENT PARTNERS, INC. 2.1K +— (+0.0%) 17.1K +1.7K (+11.1%) 0.01% 0.000 pp 0.00% +0.000 pp USD4.72 +73.3% 7 qtrs
70 QUADRANT CAPITAL GROUP LLC 1.9K -37.0 (-1.9%) 15.5K +1.2K (+8.7%) 0.01% 0.000 pp 0.00% +0.000 pp USD7.36 +11.1% 12 qtrs
71 MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. 1.8K +1.8K (+100.0%) 14.9K +14.9K (+100.0%) 0.00% +0.005 pp 0.00% +0.000 pp USD8.18 +0.0% 1 qtrs NEW
72 CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 1.7K +127.0 (+8.0%) 14.1K +2.3K (+20.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD5.00 +63.6% 7 qtrs
73 CITIGROUP INC 1.7K +703.0 (+71.2%) 13.8K +6.6K (+90.3%) 0.00% +0.002 pp 0.00% +0.000 pp USD6.63 +23.4% 54 qtrs
74 NEW YORK STATE COMMON RETIREMENT FUND 1.5K +— (+0.0%) 12.3K +1.2K (+11.1%) 0.00% +0.000 pp 0.00% +0.000 pp USD4.72 +73.3% 7 qtrs
75 TOWER RESEARCH CAPITAL LLC (TRC) 1.4K -1.6K (-52.5%) 11.7K -10.5K (-47.3%) 0.00% -0.004 pp 0.00% 0.000 pp USD6.41 +27.6% 23 qtrs
76 QUARRY LP 1.4K -2.4K (-63.0%) 11.5K -16.4K (-58.9%) 0.00% -0.007 pp 0.00% -0.004 pp USD7.36 +11.1% 2 qtrs
77 SIMPLEX TRADING, LLC 1.3K -2.1K (-60.9%) 10.9K -14.1K (-56.5%) 0.00% -0.006 pp 0.00% +0.000 pp USD7.36 +11.1% 2 qtrs
78 ROYAL BANK OF CANADA 1.3K -121.7K (-99.0%) 10.0K -895.0K (-98.9%) 0.00% -0.329 pp 0.00% 0.000 pp USD8.03 +1.9% 25 qtrs
79 KEY FINANCIAL INC 1.1K +— (+0.0%) 9.2K +1.1K (+14.1%) 0.00% +0.000 pp 0.00% +0.000 pp USD8.12 +0.7% 3 qtrs
80 KEMNAY ADVISORY SERVICES INC. 975.00 +975.0 (+100.0%) 8.0K +8.0K (+100.0%) 0.00% +0.003 pp 0.00% +0.001 pp USD8.18 +0.0% 1 qtrs NEW
81 AMALGAMATED BANK 877.00 +140.0 (+19.0%) 7.0K +2.0K (+40.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD5.27 +55.2% 7 qtrs
82 CWM, LLC 854.00 -64.0 (-7.0%) 7.0K +— (+0.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD6.16 +32.8% 13 qtrs
83 NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 825.00 +— (+0.0%) 6.7K +677.0 (+11.1%) 0.00% +0.000 pp 0.00% +0.000 pp USD9.22 -11.3% 18 qtrs
84 GF FUND MANAGEMENT CO. LTD. 736.00 +736.0 (+100.0%) 6.0K +6.0K (+100.0%) 0.00% +0.002 pp 0.00% +0.000 pp USD8.18 +0.0% 1 qtrs NEW
85 PNC FINANCIAL SERVICES GROUP, INC. 661.00 +400.0 (+153.3%) 5.4K +3.5K (+181.5%) 0.00% +0.001 pp 0.00% +0.000 pp USD7.30 +12.1% 13 qtrs
86 STERLING CAPITAL MANAGEMENT LLC 660.00 +81.0 (+14.0%) 5.4K +1.1K (+26.7%) 0.00% +0.000 pp 0.00% +0.000 pp USD7.40 +10.5% 6 qtrs
87 SMARTLEAF ASSET MANAGEMENT LLC 620.00 +— (+0.0%) 5.0K +583.0 (+13.2%) 0.00% +0.000 pp 0.00% 0.000 pp USD7.36 +11.1% 5 qtrs
88 GAMMA INVESTING LLC 593.00 +81.0 (+15.8%) 4.9K +1.1K (+28.7%) 0.00% +0.000 pp 0.00% +0.000 pp USD6.87 +19.1% 6 qtrs
89 ALLWORTH FINANCIAL LP 500.00 +— (+0.0%) 4.1K +410.0 (+11.1%) 0.00% +0.000 pp 0.00% +0.000 pp USD8.12 +0.7% 3 qtrs
90 ULLAND INVESTMENT ADVISORS, LLC 500.00 +— (+0.0%) 4.0K +— (+0.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD7.36 +11.1% 2 qtrs
91 OPTIVER HOLDING B.V. 464.00 +— (+0.0%) 3.8K +381.0 (+11.2%) 0.00% +0.000 pp 0.00% +0.000 pp USD7.36 +11.1% 2 qtrs
92 SJS INVESTMENT CONSULTING INC. 174.00 +— (+0.0%) 1.4K +143.0 (+11.2%) 0.00% +0.000 pp 0.00% +0.000 pp USD7.03 +16.4% 4 qtrs
93 FIFTH THIRD BANCORP 131.00 +— (+0.0%) 1.1K +108.0 (+11.2%) 0.00% +0.000 pp 0.00% +0.000 pp USD6.83 +19.8% 6 qtrs
94 NISA INVESTMENT ADVISORS, LLC 115.00 +— (+0.0%) 941.00 +95.0 (+11.2%) 0.00% +0.000 pp 0.00% +0.000 pp USD7.46 +9.7% 17 qtrs
95 EVERSOURCE WEALTH ADVISORS, LLC 33.00 -28.0 (-45.9%) 270.00 -179.0 (-39.9%) 0.00% 0.000 pp 0.00% +0.000 pp USD7.12 +14.9% 5 qtrs
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 21 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 ProShares Ultra Nasdaq Biotechnology BIB 0.01% 6.0K 1.19%
2 Vanguard Russell 2000 Growth ETF VTWG 0.01% 96.5K 0.06%
3 Global X - Russell 2000 ETF RSSL 0.00% 62.8K 0.08%
4 iShares U.S. Small Cap Index ETF (CAD-Hedged) XSU.TO 0.00% 23.1K 0.36%
5 Vanguard Russell 2000 ETF VTWO 0.00% 708.1K 0.06%
6 Vanguard Extended Market ETF VXF 0.00% 2.14M 0.05%
7 Vanguard Russell 2000 Value ETF VTWV 0.00% 26.0K 0.06%
8 ProShares - Ultra Russell2000 UWM 0.00% 5.3K 1.07%
9 ProShares - UltraPro Russell2000 URTY 0.00% 5.1K 1.08%
10 ProShares - Hedge Replication ETF HDG 0.00% 128.26 0.95%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
1
Shares acquired
Shares disposed
24.6K
Cash buys
Cash sales
Net activity
-24,645
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-04-14 Salus Thomas D. Officer F-InKind D Common Stock 24,645 5.20 128.2K 246,333 D
2026-03-02 Salus Thomas D. Officer A-Award A Common Stock 30,000 0.00 270,978 D
2025-09-03 Lake Ryan David Officer F-InKind D Common Stock 22,932 7.71 176.8K 336,691 D
2025-07-15 Schechter Joshua Director A-Award A Common Stock 19,506 0.00 107,173 D
2025-07-15 OBUS NELSON Director A-Award A Common Stock 19,506 0.00 138,193 D
2025-07-15 Korenberg Matthew E Director A-Award A Common Stock 19,506 0.00 44,060 D
2025-07-15 Kiper Christopher S Director / 10% Owner A-Award A Common Stock 19,506 0.00 77,575 D
2025-07-15 Johnson Paul Harold Director A-Award A Common Stock 19,506 0.00 44,060 D
2025-07-15 HOUDE LOVAS KATRINA Director A-Award A Common Stock 19,506 0.00 109,412 D
2025-07-15 Aryeh Jason Director A-Award A Common Stock 19,506 0.00 44,060 D
2025-07-15 Antunes Humberto Calheiros Director A-Award A Common Stock 19,506 0.00 47,060 D
2025-07-08 Salus Thomas D. Officer F-InKind D Common Stock 11,022 8.19 90.3K 240,978 D
2025-07-08 Lake Ryan David Officer F-InKind D Common Stock 32,806 8.19 268.7K 359,623 D
2025-07-08 Josephs Paul Director / Officer F-InKind D Common Stock 54,857 8.19 449.3K 633,328 D
2025-05-28 English Aron R. 10% Owner S-Sale D Common Stock 150,419 7.12 1.07M 264,180 I
2025-05-27 English Aron R. 10% Owner S-Sale D Common Stock 1,139,504 6.50 7.41M 414,599 I
2025-05-23 English Aron R. 10% Owner S-Sale D Common Stock 96,137 6.75 649.4K 1,554,103 I
2025-05-20 Josephs Paul Director / Officer F-InKind D Common Stock 21,532 6.63 142.8K 538,185 D
2025-05-13 English Aron R. 10% Owner S-Sale D Common Stock 12,334 7.00 86.4K 1,650,240 I
2025-05-12 English Aron R. 10% Owner S-Sale D Common Stock 45,698 7.03 321.4K 1,662,574 I
2025-05-09 English Aron R. 10% Owner S-Sale D Common Stock 700 7.00 4.9K 1,708,272 I
2025-05-08 English Aron R. 10% Owner S-Sale D Common Stock 5,098 7.00 35.7K 1,708,972 I
2025-05-07 English Aron R. 10% Owner S-Sale D Common Stock 15,847 7.01 111.1K 1,714,070 I
2025-05-06 English Aron R. 10% Owner S-Sale D Common Stock 701 7.05 4.9K 1,729,917 I
2025-05-05 English Aron R. 10% Owner S-Sale D Common Stock 24,543 7.08 173.8K 1,730,618 I
2025-04-14 Salus Thomas D. Officer A-Award A Common Stock 45,000 0.00 45,000 D
2025-01-08 Josephs Paul Director / Officer P-Purchase A Common Stock 17,000 5.74 97.6K 559,717 D
2024-12-06 Lake Ryan David Officer A-Award A Common Stock 19,720 0.00 323,082 D
2024-12-06 Josephs Paul Director / Officer A-Award A Common Stock 38,461 0.00 554,486 D
2024-10-07 Lake Ryan David Officer M-Exempt A Common Stock 75,000 0.00 337,500 D
2024-10-03 WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% Owner P-Purchase A Common Stock, $0.001 par value per share 169,753 4.10 696.0K 2,607,433 I
2024-10-03 Kiper Christopher S Director / 10% Owner P-Purchase A Common Stock 1,311,312 4.10 5.38M 4,084,268 I
2024-09-03 Lake Ryan David Officer A-Award A Common Stock 262,500 0.00 262,500
2024-08-19 Korenberg Matthew E Director A-Award A Common Stock 24,554 0.00 24,554
2024-08-19 Johnson Paul Harold Director A-Award A Common Stock 24,554 0.00 24,554
2024-08-19 Aryeh Jason Director A-Award A Common Stock 24,554 0.00 24,554
2024-08-19 Antunes Humberto Calheiros Director A-Award A Common Stock 24,554 0.00 24,554
2024-08-15 Korenberg Matthew E Director D No Security beneficially owned 0 0.00 0
2024-08-15 Johnson Paul Harold Director D No Security beneficially owned 0 0.00 0
2024-08-15 Aryeh Jason Director D No Security beneficially owned 0 0.00 0
2024-08-15 Antunes Humberto Calheiros Director D No Security beneficially owned 0 0.00 0
2024-07-08 Schechter Joshua Director A-Award A Common Stock 30,000 0.00 87,667
2024-07-08 OBUS NELSON Director A-Award A Common Stock 30,000 0.00 118,687
2024-07-08 Kiper Christopher S Director A-Award A Common Stock 30,000 0.00 58,069
2024-07-08 HOUDE LOVAS KATRINA Director A-Award A Common Stock 30,000 0.00 89,906
2024-07-08 EDWARDS JEFFREY L Director A-Award A Common Stock 30,000 0.00 79,667
2024-07-08 Diradoorian Raymond H Director A-Award A Common Stock 30,000 0.00 69,978
2024-07-08 Calloway Nathaniel Director A-Award A Common Stock 30,000 0.00 58,069
2024-07-08 Barbarosh Craig A. Director A-Award A Common Stock 30,000 0.00 88,073
2024-05-20 Josephs Paul Director / Officer A-Award A Performance-Based Restricted Stock Units 1,500,000 0.00 0
2024-02-01 Schechter Joshua Director M-Exempt A Common Stock 9,554 0.00 57,667
2024-02-01 OBUS NELSON Director M-Exempt D Restricted Stock Unit 9,554 0.00 0
2024-02-01 HOUDE LOVAS KATRINA Director M-Exempt D Restricted Stock Unit 9,554 0.00 0
2024-02-01 EDWARDS JEFFREY L Director M-Exempt D Restricted Stock Unit 9,554 0.00 0
2024-02-01 Diradoorian Raymond H Director M-Exempt D Restricted Stock Unit 9,554 0.00 0
2024-02-01 Calloway Nathaniel Director M-Exempt D Restricted Stock Unit 3,981 0.00 0
2024-02-01 Barbarosh Craig A. Director M-Exempt D Restricted Stock Unit 9,554 0.00 0
2024-01-18 Morberg John D Officer M-Exempt A Common Stock 17,500 0.00 131,900
2024-01-09 Calloway Nathaniel Director M-Exempt D Restricted Stock Unit 5,906 0.00 0
2023-06-01 Schechter Joshua Director A-Award A Common Stock 18,182 0.00 48,113
2023-06-01 OBUS NELSON Director A-Award A Common Stock 18,182 0.00 79,133
2023-06-01 Morberg John D Officer A-Award A Common Stock 50,000 0.00 114,400
2023-06-01 Kiper Christopher S Director A-Award A Common Stock 18,182 0.00 28,069
2023-06-01 Hall James G Director / Officer A-Award A Common Stock 150,000 0.00 201,096
2023-06-01 HOUDE LOVAS KATRINA Director A-Award A Common Stock 18,182 0.00 50,352
2023-06-01 EDWARDS JEFFREY L Director A-Award A Common Stock 18,182 0.00 40,113
2023-06-01 Diradoorian Raymond H Director A-Award A Common Stock 18,182 0.00 30,424
2023-06-01 Calloway Nathaniel Director A-Award A Common Stock 18,182 0.00 18,182
2023-06-01 Barbarosh Craig A. Director A-Award A Common Stock 18,182 0.00 48,519
2023-05-31 Schechter Joshua Director M-Exempt D Restricted Stock Unit 9,474 0.00 0
2023-05-31 OBUS NELSON Director M-Exempt D Restricted Stock Unit 9,474 0.00 0
2023-05-31 HOUDE LOVAS KATRINA Director M-Exempt A Common Stock 9,474 0.00 32,170
2023-05-31 EDWARDS JEFFREY L Director M-Exempt D Restricted Stock Unit 9,474 0.00 0
2023-05-31 Diradoorian Raymond H Director M-Exempt D Restricted Stock Unit 9,474 0.00 0
2023-05-31 Barbarosh Craig A. Director M-Exempt D Restricted Stock Unit 9,474 0.00 0
2023-02-01 Schechter Joshua Director A-Award A Restricted Stock Unit 9,554 0.00 9,554
2023-02-01 OBUS NELSON Director A-Award A Restricted Stock Unit 9,554 0.00 9,554
2023-02-01 Kiper Christopher S Director A-Award A Common Stock 3,981 0.00 9,887
2023-02-01 HOUDE LOVAS KATRINA Director A-Award A Restricted Stock Unit 9,554 0.00 9,554
2023-02-01 EDWARDS JEFFREY L Director A-Award A Restricted Stock Unit 9,554 0.00 9,554
2023-02-01 Diradoorian Raymond H Director A-Award A Restricted Stock Unit 9,554 0.00 9,554
2023-02-01 Calloway Nathaniel Director A-Award A Restricted Stock Unit 3,981 0.00 3,981
2023-02-01 Barbarosh Craig A. Director A-Award A Restricted Stock Unit 9,554 0.00 9,554
2023-01-20 Diradoorian Raymond H Director A-Award A Common Stock 2,768 7.00 19.4K 2,768
2023-01-09 WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% Owner P-Purchase A Series A Convertible Preferred Stock 1,040 7.00 7.3K 1,040
2023-01-09 Kiper Christopher S Director I Cash-Settled Total Return Swap 105,110 0.00 0
2023-01-09 Calloway Nathaniel Director A-Award A Restricted Stock Unit 5,906 0.00 5,906
2022-11-25 WYNNEFIELD PARTNERS SMALL CAP VALUE LP I Director P-Purchase A Common Stock, $0.001 par value per share 345,260 7.97 2.75M 1,972,853

Executive team

Top executives
EBIT / Employee
-41.8K
Shares Outstanding
37.48M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-04-24 DEF 14A
2025-09-18 DEF 14A
2025-02-27 DEF 14A
2025-01-21 PRE 14A
2025-01-17 DEFA14A
2024-09-23 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-06 8-K
2026-05-06 10-Q
2026-04-27 SC 13G/A
2026-04-24 DEF 14A
2026-04-16 4
2026-03-16 8-K
2026-03-16 10-KT
2026-03-05 8-K
2026-03-02 4
2026-01-21 SC 13G

Executive team

NameTitleCompensationGender
Paul Josephs President, Chief Executive Officer & Director 545.6K male
Ryan D. Lake Executive Vice President & Chief Financial Officer 406.7K male
Thomas Salus Chief Legal and Administration Officer & Corporate Secretary 383.8K male
Parker K. Javid Vice President 321.9K male
Mark DaFonseca Chief Commercial Officer male
Jackie Q. Klecker Executive Vice President of Quality & Development Services female
Thomas Guldager Senior Vice President of Operations male
Aaron Perlitsh Director of Internal Audit & Chief Compliance Officer male
ESG Rating
B
DRUG MANUFACTURERS - SPECIALTY & GENERIC
2026
E (Environmental)
61.2 / 66.0
Company / Sector avg.
S (Social)
71.9 / 70.0
Company / Sector avg.
G (Governance)
69.4 / 66.6
Company / Sector avg.
ESG Total
67.5 / 67.5
Company / Sector avg.
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits